HEDY CAMPOS: Open Payments
NPI 1023261195 · FREDERICKSBURG, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$555 in 34 payments from 9 companies in 2025. Trend: 2023 $345 · 2024 $120 · 2025 $555
Food & beverage: $444Education: $111
| Company | Payments | Amount |
|---|---|---|
| Neurocrine BioSciences, Inc. | 17 | $148 |
| Teva Pharmaceuticals USA, Inc. | 3 | $137 |
| Otsuka America Pharmaceutical, Inc. | 3 | $61 |
| Axsome Therapeutics, Inc. | 3 | $57 |
| Lundbeck LLC | 2 | $44 |
| ABBVIE INC. | 2 | $35 |
| Vanda Pharmaceuticals Inc. | 2 | $33 |
| E.R. Squibb & Sons, L.L.C. | 1 | $26 |
| Supernus Pharmaceuticals, Inc. | 1 | $14 |
Products named: INGREZZA, REXULTI, Auvelity, VRAYLAR, FANAPT, COBENFY, AUSTEDO XR, Qelbree.
Industry payments across VA — which companies pay providers there.
